McKesson Corporation $MCK Stock: Vise Technologies Inc. Raises Holdings

Vise Technologies Inc. increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 11.5% in the third quarter, HoldingsChannel reports. The firm owned 8,393 shares of the company’s stock after buying an additional 866 shares during the period. Vise Technologies Inc.’s holdings in McKesson were worth $7,166,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Nvwm LLC lifted its position in shares of McKesson by 933.3% in the third quarter. Nvwm LLC now owns 31 shares of the company’s stock valued at $26,000 after buying an additional 28 shares during the last quarter. Delos Wealth Advisors LLC bought a new position in shares of McKesson during the 2nd quarter worth approximately $27,000. Trellis Wealth Advisors LLC bought a new position in shares of McKesson during the 3rd quarter worth approximately $32,000. GK Wealth Management LLC acquired a new position in shares of McKesson during the 3rd quarter worth approximately $38,000. Finally, Curry Webb Wealth Management LLC acquired a new position in shares of McKesson during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Trading Up 0.7%

NYSE:MCK opened at $1,001.05 on Tuesday. The stock has a market cap of $116.71 billion, a P/E ratio of 26.79, a PEG ratio of 1.91 and a beta of 0.30. The stock has a 50 day simple moving average of $925.32 and a 200 day simple moving average of $863.78. McKesson Corporation has a 1-year low of $723.68 and a 1-year high of $1,030.27.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The business had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. During the same period in the previous year, the company posted $8.26 EPS. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, sell-side analysts forecast that McKesson Corporation will post 44.71 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be given a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s payout ratio is presently 10.06%.

Insider Activity at McKesson

In related news, Director Bradley Lerman sold 301 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO B Jr sold 111 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares in the company, valued at approximately $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,212 shares of company stock worth $1,164,182. Corporate insiders own 0.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Mizuho increased their price target on McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research note on Tuesday, October 20th. Argus upped their price objective on shares of McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $845.00 price objective on shares of McKesson in a report on Monday, September 14th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a research report on Saturday, October 17th. Finally, Barclays raised their target price on shares of McKesson from $925.00 to $1,000.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 19th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and an average target price of $997.12.

McKesson Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.